Work

Phase I Trial of ISIS 104838, a 2′-Methoxyethyl Modified Antisense Oligonucleotide Targeting Tumor Necrosis Factor-α

Year: 2002

Type: article

Source: Journal of Pharmacology and Experimental Therapeutics

DOI: 10.1124/jpet.102.036749

Authors: K. Lea Sewell, Richard S. Geary, Brenda F. Baker, Josephine M. Glover, Timothy G.K. Mant, Rosie Z. Yu, Joseph A. Tami, F. Andrew Dorr

Institution: Ionis Pharmaceuticals (United States)

Language: English

Topic: RNA Interference and Gene Delivery

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Francis Crick Institute

OpenAlex ID: W2104954969

FWCI: 1.625

Cites: 36

Cited by: 122

Related to: 10